Boston Scientific announced Wednesday its acquisition of chronic pain treatment firm Cosman Medical, as the Marlborough company keeps its eyes set on non-opioid treatments.
The acquisition of the private Burlington company is a natural fit with Boston Scientific’s current portfolio, according to a release from the company, that includes its own spinal cord stimulator systems that can be used in the place of opioids to combat chronic pain.Â
Cosman Medical’s lineup includes radiofrequency ablation (RFA) systems that have been done in outpatient settings for 50 years, according to Boston Scientific. The Cosman Medical team and products will become part of the Boston Scientific neuromodulation business.
The expansion into RFA follows the recent Boston Scientific launch of the Precision Montage MRI Spinal Cord Stimulator System which offers customized relief to patients with chronic pain while also enabling safe access to full body magnetic resonance imaging, according to the company.
No financials were released related to the acquisition.
